期刊
JOURNAL OF APPLIED MICROBIOLOGY
卷 117, 期 5, 页码 1253-1259出版社
WILEY
DOI: 10.1111/jam.12618
关键词
antimicrobial peptide; antiviral activity; bacteriocin; herpes simplex virus; microbicide; subtilosin
资金
- Universidad de Buenos Aires [20020110100076]
- Bill and Melinda Gates Foundation Grand Challenges Exploration [OPP1025200]
- National Institutes of Health/National Institute of Allergy and Infectious Diseases [1R01AI084137]
- Bill and Melinda Gates Foundation [OPP1025200] Funding Source: Bill and Melinda Gates Foundation
AimsIn this study, we evaluated the antiviral activity of subtilosin, a cyclical peptide isolated from Bacillus amyloliquefaciens, against herpes simplex virus type 2 (HSV-2) in cell cultures and we investigated subtilosin mode of action. Methods and ResultsWe determined, using a virus yield inhibition assay, that noncytotoxic concentrations of subtilosin inhibit HSV-2 replication in Vero cell cultures. Subtilosin strongly inhibited extracellular and total virus production even when it was added at 8h postinfection indicating that not only virus release but also viral particle formation is impeded by the antiviral peptide. Although viral glycoprotein gD level of expression is not affected by the bacteriocin, an altered pattern of gD intracellular localization was detected by immunofluorescence assay in subtilosin-treated culture. On the other hand, at high concentrations, subtilosin displays virucidal action. ConclusionsSubtilosin displays antiviral and virucidal actions against HSV-2. The target of subtilosin inhibitory effect would be late stages of the viral replicative cycle such as viral glycoprotein intracellular transport. Significance and Impact of the StudyGiven its antimicrobial activity and its safety for human tissues, subtilosin could represent a valuable alternative to be considered in the development of new microbicide formulations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据